ORIGINAL ARTICLESSafety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion
REFERENCES (31)
- et al.
Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology
Ann Allergy Asthma Immunol
(1998) Changing prevalence of allergic rhinitis and asthma
Ann Allergy Asthma Immunol
(1999)One airway, one disease
Chest
(1997)- et al.
Epidemiologic evidence for asthma and rhinitis comorbidity
J Allergy Clin Immunol
(2000) Allergic rhinobronchitis: the asthma-allergic rhinitis link
J Allergy Clin Immunol
(1999)- et al.
Efficacy of beclomethasone nasal solution, flunisolide, and cromolyn in relieving symptoms of ragweed allergy
Mayo Clin Proc
(1987) - et al.
Effects of topical nasal treatment on asthma symptoms
J Allergy Clin Immunol
(1988) H1-receptor antagonists: safety issues
Ann Allergy Asthma Immunol
(1999)- et al.
Pharmacokinetic and safety profile of desloratadine and fexofenadine when coadministered with azithromycin: a randomized, placebo-controlled, parallel-group study
Clin Ther
(2001) The Allergy Report, Volume 1: Overview of Allergic Diseases 2000
(2000)
Allergic rhinitis: epidemiology and natural history
Allergy Asthma Proc
(2000)
The link between allergy and asthma
Allergy Asthma Proc
(1999)
The relationship between allergic rhinitis and bronchial asthma
Curr Opin Pulm Med
(1999)
Desloratadine attenuation of eosinophil chemotaxis, adhesion, and superoxide generation
Allergy
(2000)
Pharmacology and clinical efficacy of desloratadine as an anti-allergic and anti-inflammatory drug
Exp Opin Invest Drugs
(2001)
Cited by (98)
Diphenhydramine: Time to Move on?
2022, Journal of Allergy and Clinical Immunology: In PracticeEfficacy of non-sedating H1-receptor antihistamines in adults and adolescents with chronic cough: A systematic review
2021, World Allergy Organization JournalCitation Excerpt :The crossover trial by Dirksen included 17 patients with moderate asthma and reported that the cough score was lower with loratadine than with placebo, but the difference was not statistically significant (mean difference [MD] ± SD: 0.49 ± 0.19 vs. 0.83 ± 0.22; p > 0.05).31 There were 4 RCTs involving patients with allergic rhinitis and asthma.32,34–36 Since the recent use of inhaled corticosteroids was set as one of the exclusion criteria, the severity of asthma in participants was presumed to be mild in all these trials.
Review of Desloratadine Data Using the ARIA Guidelines
2012, World Allergy Organization JournalAntihistamine Therapy in Allergic Rhinitis
2011, Immunology and Allergy Clinics of North AmericaTreatment of allergic rhinitis with desloratadine: Results of a multinational observational study in the middle east gulf region
2011, World Allergy Organization JournalEffect size of various clinically tested treatments in seasonal allergic rhinitis
2011, Revue Francaise d'Allergologie
Supported by Schering-Plough Research Institute
Copyright © 2002 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.